换一批International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship.
第一作者：
Issam I,Raad
第一单位：
Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States.
作者：
Issam I,Raad [1]
;
Ray,Hachem [1]
;
Nigo,Masayuki [2]
;
Tarcila,Datoguia [3]
;
Hiba,Dagher [1]
;
Ying,Jiang [1]
;
Vivek,Subbiah [4]
;
Bilal,Siddiqui [5]
;
Arnaud,Bayle [6]
;
Robert,Somer [7]
;
Ana,Fernández Cruz [8]
;
Edward,Gorak [9]
;
Arvinder,Bhinder [10]
;
Nobuyoshi,Mori [11]
;
Nelson,Hamerschlak [3]
;
Samuel,Shelanski [12]
;
Tomislav,Dragovich [13]
;
Yee Elise,Vong Kiat [14]
;
Suha,Fakhreddine [15]
;
Abi Hanna,Pierre [15]
;
Roy F,Chemaly [1]
;
Victor,Mulanovich [1]
;
Javier,Adachi [1]
;
Jovan,Borjan [1]
;
Fareed,Khawaja [1]
;
Bruno,Granwehr [1]
;
Teny,John [1]
;
Eduardo Yepez,Yepez [1]
;
Harrys A,Torres [1]
;
Natraj Reddy,Ammakkanavar [16]
;
Marcel,Yibirin [1]
;
Cielito C,Reyes-Gibby [17]
;
Mala,Pande [18]
;
Noman,Ali [19]
;
Raniv Dawey,Rojo [20]
;
Shahnoor M,Ali [1]
;
Rita E,Deeba [1]
;
Patrick,Chaftari [17]
;
Takahiro,Matsuo [11]
;
Kazuhiro,Ishikawa [11]
;
Ryo,Hasegawa [11]
;
Ramón,Aguado-Noya [21]
;
Alvaro Garcia,García [22]
;
Cristina Traseira,Puchol [21]
;
Dong Gun,Lee [23]
;
Monica,Slavin [24]
;
Benjamin,Teh [24]
;
Cesar A,Arias [2]
;
Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team [25]
;
Dimitrios P,Kontoyiannis [1]
;
Alexandre E,Malek [1]
;
Anne-Marie,Chaftari [1]
作者单位：
Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, United States.
[1]
Division of Infectious Diseases, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, United States.
[2]
Médica Hematologista Hospital Israelita Albert Einstein, São Paulo, Brazil.
[3]
MD Anderson Cancer Network, UT MD Anderson Cancer Center, Houston, United States.;Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, United States.
[4]
Department of Hematology Oncology, Community Health Network, Indianapolis, United States.
[5]
Department of Medical Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
[6]
Cooper Medical School of Rowan University, Cooper University Health Care, Camden, United States.
[7]
Unidad de Enfermedades Infecciosas, Servicio de Medicina Interna, Hospital Universitario Puerta de Hierro, Madrid, Spain.
[8]
Department of Hematology Oncology, Baptist Health, Jacksonville, United States.
[9]
Department of Hematology/Oncology, Ohio Health Marion, Marion, United States.
[10]
Department of Infectious Diseases, St. Luke's International Hospital, Tokyo, Japan.
[11]
Banner MD Anderson Cancer Center - North Colorado, Greely, United States.
[12]
Division of Cancer Medicine, Banner MD Anderson Cancer Center, Gilbert, United States.
[13]
Department of Medical Oncology, Tan Tock Seng Hospital, Singapore, Singapore.
[14]
Department of Infectious Diseases, Rafik Hariri University Hospital, Beirut, Lebanon.
[15]
Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, United States.
[16]
Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, United States.
[17]
Department of Gastroenterology, The University of Texas MD Anderson Cancer Center, Houston, United States.
[18]
Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, United States.
[19]
Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States.
[20]
Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
[21]
Hematology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
[22]
Division of Infectious Diseases, Department of Internal Medicine, Vaccine Bio Research Institute, The Catholic University of Korea, Seoul, Republic of Korea.
[23]
Department of Infectious Diseases and National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia.
[24]
Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team at The University of Texas MD Anderson Cancer Center, Houston, United States.
[25]
医学主题词
人类(Humans);回顾性研究(Retrospective Studies);危险因素(Risk Factors);肿瘤(Neoplasms);淋巴细胞减少(Lymphopenia);氧(Oxygen)
DOI
10.7554/eLife.81127
PMID
36715684
发布时间
2023-03-21
- 浏览1
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
